News
Bayer wins fifth consecutive trial on charges Roundup weedkiller causes cancer Initial multimillion-dollar verdicts were for individual plaintiffs (Reuters) - Bayer AG has won its fifth ...
The future of Roundup, the world’s most widely used herbicide, hangs in the balance as chemical maker Bayer (OTCPK:BAYZF) (OTCPK:BAYRY) signals it may soon halt production unless it receives ...
Seven years ago, two events set forth a domino effect culminating in Bayer leaders having a potential “tough decision” of whether or not the company will continue to manufacture its legacy ...
Faced with huge debt, the impending expiry of a crucial patent, and ongoing litigation over a horror acquisition, Bayer CEO Bill Anderson made a bold move a year ago to get his damaged company ...
Xabi Alonso has transformed Bayer Lerverkusen since becoming head coach in 2022. Christian Kaspar-Bartke/Getty Images Carro said he is keen for Leverkusen to see out the remainder of his ...
Bayer was ordered by a jury in Georgia to pay about $2.1 billion to a plaintiff who claimed the company's Roundup weed killer caused his cancer, the plaintiff's law firms said on Friday.
I was no stranger to the tensions at Bayer when I joined as CEO last June. Multiple complex challenges face our business. There’s the ongoing–and unjustified–litigation around glyphosate ...
Bayer is exiting the seed treatment equipment business in the United States to help the company’s finances, according to an email sent to customers that was seen by Reuters on Wednesday.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results